StockWatch
·
Pharmaceuticals
Management Change29 Jun 2026, 06:30 pm

Bacil Pharma Appoints Two Non-Executive Independent Directors

AI Summary

Bacil Pharma Limited has announced its intention to appoint two new Non-Executive Independent Directors, Mr. Aayush Shah and Mr. Ankitkumar Surendrakumar Agrawal, to its Board of Directors. Mr. Shah brings nine years of experience in Company Secretary and Compliance Officer roles, with expertise in corporate laws, capital markets, and corporate governance. Mr. Agrawal, a qualified Company Secretary with over seven years of experience, also possesses strong knowledge in corporate laws and regulatory liaison. Both appointments are subject to approval in the upcoming Board Meeting and will be liable to retire by rotation, requiring shareholder approval at the next General Meeting. These appointments aim to strengthen the board's governance and compliance oversight.

Key Highlights

  • Bacil Pharma proposes to appoint two new Non-Executive Independent Directors.
  • Appointees have extensive experience in Company Secretary and compliance roles.
  • Appointments aim to enhance corporate governance and regulatory compliance.
  • Director appointments require shareholder approval at the next General Meeting.